Bimatoprost vs Latanoprost: Differences, Similarities & Which Is Right for You

If you’ve been diagnosed with open-angle glaucoma or ocular hypertension, there’s a good chance your eye doctor mentioned one of two medications: bimatoprost or latanoprost. Both belong to the same broad family of glaucoma treatments, both are dosed just once a day, and both have built strong reputations over more than two decades of clinical use. So why does one get prescribed over the other — and does it actually matter which one you use?

This guide breaks down exactly how bimatoprost and latanoprost compare: how they work, how effective each is, what side effects to expect, how their eyelash-growth effects differ, and how to consider cost when choosing between them.

Quick Comparison: Bimatoprost vs Latanoprost

	Latanoprost	Bimatoprost
Drug class	Prostaglandin F2-alpha analogue	Prostamide (synthetic prostaglandin analogue)
Common brand names	Xalatan, 9 PM Eye Drop	Lumigan, Careprost, Bimat
Standard concentration	0.005%	0.03% (0.01% in some formulations)
Primary outflow pathway affected	Uveoscleral pathway	Uveoscleral and trabecular pathway
Dosing	Once daily, evening	Once daily, evening
IOP-lowering effect	Strong	Strong, often comparable or slightly greater
Eyelash growth effect	Noticeable	More pronounced — FDA-approved for this use (as Latisse)
Typical cost	Lower	Slightly higher (brand); comparable in generic form

Both drugs are considered first-line treatments for glaucoma, and in most patients, either one will achieve the pressure control your doctor is targeting. The differences come down to degree, not direction.

What Is Latanoprost?

Latanoprost is a prostaglandin analogue used to reduce elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. It was one of the first prostaglandin analogues approved for glaucoma and remains one of the most widely prescribed eye pressure medications in the world, largely because of its strong efficacy, manageable side-effect profile, and long track record of safety data.

At PremiumRxDrugs, latanoprost is available as the 9 PM Eye Drop, a 0.005% generic formulation equivalent to branded Xalatan.

What Is Bimatoprost?

Bimatoprost is technically classified as a prostamide rather than a true prostaglandin analogue, though the two terms are often used loosely in casual comparisons. Structurally and functionally, bimatoprost behaves very similarly to latanoprost, but it’s believed to act on a slightly broader set of drainage pathways in the eye, which is part of why some patients see marginally greater pressure reduction with it.

Bimatoprost is sold under brand names such as Lumigan for glaucoma treatment and as Careprost and Bimat in markets where it’s also marketed for cosmetic eyelash growth.

How Do They Lower Eye Pressure? (Mechanism of Action)

Both medications target the same underlying problem: in glaucoma, fluid inside the eye (aqueous humour) doesn’t drain efficiently, causing pressure to build and gradually damage the optic nerve. Both drugs work by increasing how much fluid drains out of the eye, rather than by reducing how much fluid the eye produces, which is the strategy used by older drug classes like beta-blockers.

• Latanoprost primarily increases outflow through the uveoscleral pathway, one of the eye’s two drainage routes.
• Bimatoprost also enhances uveoscleral outflow, but research suggests it may also improve drainage through the trabecular meshwork, the eye’s other primary outflow route, sometimes called the “conventional” pathway.

This broader mechanism is one reason bimatoprost is occasionally favoured in patients who haven’t responded as strongly to latanoprost — targeting both outflow pathways can produce a meaningfully larger pressure drop in some individuals, even though both drugs operate on the same general principle.

Which One Lowers Eye Pressure More Effectively?

Numerous head-to-head clinical trials have directly compared bimatoprost and latanoprost, and the overall pattern is consistent: both are highly effective, with a small gap between them. Several studies have found bimatoprost produces a slightly greater reduction in IOP — often by a small additional percentage — particularly in patients with higher baseline pressure. Other studies have found the two drugs perform comparably, with no statistically meaningful difference.

In practical terms, this means neither drug is “better” in a way that applies to every patient. An eye doctor will often choose based on a patient’s specific pressure target, how their eyes respond during a trial period, tolerance for side effects, and sometimes simply availability or cost. If one medication doesn’t bring pressure down enough, switching to the other — or combining a prostaglandin with a different drug class — is a common and effective next step.

Side Effects: How Do They Compare?

Because bimatoprost and latanoprost work through similar mechanisms, their side-effect profiles overlap heavily. Both are generally well tolerated, with most side effects being mild, localised to the eye, and manageable.

Side effects common to both drugs:

• Mild stinging or burning after application
• Eye redness or irritation
• Itching
• Blurred vision immediately after use
• Gradual, often permanent darkening of the iris (more noticeable in lighter-colored eyes)
• Increased eyelash length, thickness, and pigmentation

Where they tend to differ slightly:

• Bimatoprost is somewhat more likely to cause conjunctival redness (eye redness) than latanoprost in comparative studies.
• In some trials, Latanoprost eye drops have a marginally lower rate of reported eye irritation overall, making it a common first choice for patients who are especially sensitive to ocular discomfort.
• Periorbital changes — mild fat loss around the eye socket that can subtly change eyelid appearance over long-term use — have been reported more frequently with bimatoprost, though this effect is uncommon with either drug.

Neither drug carries a meaningfully higher risk of serious systemic side effects, since both are applied topically in very small doses and absorb minimally into the bloodstream.

Eyelash Growth: Why Bimatoprost Is the Bigger Cosmetic Name

Both medications were discovered, somewhat by accident, to dramatically increase eyelash growth as a side effect of treating glaucoma. Patients using either drug noticed their lashes growing longer, thicker, darker, and more numerous over weeks of use — and pharmaceutical companies eventually built entire cosmetic product lines around this effect.

Latanoprost does produce real, measurable eyelash growth, and several studies have documented increases in lash length, density, and pigmentation with regular use.

However, bimatoprost is widely considered the more potent eyelash enhancer of the two, to the point that a specific low-concentration bimatoprost formulation (marketed as Latisse) became the first FDA-approved treatment for hypotrichosis — inadequate or sparse eyelashes — sold specifically for cosmetic use rather than glaucoma. This is the same active ingredient found in Careprost, which has become popular precisely because it offers the same lash-enhancing effect as Latisse at a fraction of the cost.

If eyelash growth is your primary goal rather than glaucoma treatment, bimatoprost-based products are generally the stronger choice. If you’re being treated for elevated eye pressure and notice longer lashes along the way, consider it a welcome side effect rather than the main event.

Dosing and How to Use Them

Both medications follow a nearly identical routine:

1. Apply one drop to the affected eye(s) once daily.
2. Use it in the evening — both drugs show slightly better pressure control with nighttime dosing compared to morning use.
3. Avoid touching the dropper tip to your eye or eyelid to prevent contamination.
4. Wait at least five minutes before applying any other eye drop.
5. If you wear contact lenses, remove them before application and wait 15 minutes before reinserting.

Consistency matters more than precise timing — using either drug at roughly the same time each night, every night, is what produces stable long-term pressure control. Skipping doses or using them irregularly significantly reduces their effectiveness.

Cost Comparison

Branded bimatoprost (Lumigan) and branded latanoprost (Xalatan) are both significantly more expensive than their generic counterparts, and pricing can vary considerably between pharmacies. As generics, both drugs become far more affordable while delivering the same active ingredient at the same concentration as the brand-name version.

At PremiumRxDrugs, generic latanoprost (9 PM Eye Drop) is typically priced lower than generic bimatoprost (Careprost/Bimat), making it an attractive entry point for patients starting treatment, while bimatoprost’s added cosmetic appeal often justifies its slightly higher price for patients specifically interested in the eyelash benefit.

Which One Should You Choose?

For most patients, the choice between bimatoprost and latanoprost comes down to how your eyes respond, not which drug is theoretically “stronger.” Some general patterns to keep in mind:

• Choose latanoprost if: you’re starting glaucoma treatment for the first time, want a well-established option with a long safety record, or are particularly sensitive to eye irritation.
• Choose bimatoprost if: your pressure didn’t respond adequately to latanoprost, your doctor wants to target both major drainage pathways, or you’re specifically interested in the eyelash growth benefit alongside pressure control.
• Either way: this decision should be made with your ophthalmologist, who can monitor your IOP over several weeks and adjust treatment based on your actual results — not a generic comparison.

Frequently Asked Questions

Can I switch from latanoprost to bimatoprost (or vice versa) without a problem? Switching between prostaglandin-class medications is common in glaucoma management and is generally done under medical supervision when one drug isn’t achieving the target pressure reduction.

Is bimatoprost stronger than latanoprost? In some studies, yes — bimatoprost has shown slightly greater average IOP reduction — but the difference is often small, and many patients achieve their target pressure equally well on either drug.

Will my eye colour change with either drug? Yes, both can cause permanent darkening of the iris, particularly in people with hazel, green, or light brown eyes. This is a known, well-documented effect of the entire prostaglandin drug class.

Can I use either drug just for eyelash growth, without having glaucoma? Bimatoprost-based products are specifically marketed and used for cosmetic eyelash enhancement. Using either medication should still be discussed with a healthcare provider, since they remain prescription products with potential side effects.

Do both drugs require a prescription? Yes. Both latanoprost and bimatoprost are prescription medications and should only be used under the guidance of an eye care professional.

Final Thoughts

Bimatoprost and latanoprost are two of the most trusted names in modern glaucoma management, and the choice between them is rarely a matter of one being objectively superior. Both deliver strong, reliable pressure reduction with a once-daily routine, both carry a similar (and generally mild) side-effect profile, and both offer the well-known bonus of fuller, longer eyelashes. The right choice depends on your individual response, your doctor’s clinical judgment, and — for some patients — whether the eyelash effect is a side benefit or the main reason for treatment.

This article is for informational purposes only and does not replace professional medical advice. Bimatoprost and latanoprost are prescription medications — consult an ophthalmologist before starting, switching, or stopping any glaucoma treatment.